Increased expression of activating transcription factor 3 is related to the biologic behavior of cutaneous squamous cell carcinomas

Human Pathology

Volumn 42, Issue 7, 2011, Pages 954-959

  Kim, Myoung Shin ^a   In, Seung Gyun ^b   Park, Oun Jae ^a   Won, Chong Hyun ^a   Lee, Mi Woo ^a   Choi, Jee Ho ^a   Kim, Chan Woong ^c   Kim, Sung Eun ^c   Moon, Kee Chan ^a   Chang, Sungeun ^a  

^a University of Ulsan College of Medicine   (South Korea)

^b Inha University Hospital   (South Korea)

^c Chung Ang University College of Medicine   (South Korea)

Author keywords

Activating transcription factor 3; Skin neoplasms; Squamous cell carcinoma

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 3; IMMUNOSUPPRESSIVE AGENT;

ACTINIC KERATOSIS; ADULT; AGED; ALLOTRANSPLANTATION; ARTICLE; BASAL CELL CARCINOMA; BOWEN DISEASE; CARCINOGENESIS; CLINICAL ARTICLE; CONTROLLED STUDY; CUTANEOUS SQUAMOUS CELL CARCINOMA; FEMALE; GRAFT RECIPIENT; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE TREATMENT; MALE; METASTASIS; PROTEIN EXPRESSION; SKIN CANCER; SQUAMOUS CELL CARCINOMA;

ACTIVATING TRANSCRIPTION FACTOR 3; ADULT; AGED; AGED, 80 AND OVER; BOWEN'S DISEASE; CARCINOMA, BASAL CELL; CARCINOMA, SQUAMOUS CELL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; SKIN NEOPLASMS;

EID: 79959359198     PISSN: 00468177     EISSN: 15328392     Source Type: Journal    
DOI: 10.1016/j.humpath.2010.10.008     Document Type: Article

References (25)

1. Hai T, Hartman MG. The molecular biology and nomenclature of the activating transcription factor/cAMP responsive element binding family of transcription factors: activating transcription factor proteins and homeostasis. Gene 2001;273:1-11. (Pubitemid 32718721)
2. Wang A, Arantes S, Conti C, et al. Epidermal hyperplasia and oral carcinoma in mice overexpressing the transcription factor ATF3 in basal epithelial cells. Mol Carcinog 2007;46:476-87. (Pubitemid 46897052)
3. Yin X, Dewille JW, Hai T. A potential dichotomous role of ATF3, an adaptive-response gene, in cancer development. Oncogene 2008;27: 2118-27. (Pubitemid 351483383)
4. Koike M, Ninomiya Y, Koike A. Characterization of ATF3 induction after ionizing radiation in human skin cells. J Radiat Res (Tokyo) 2005;46:379-85. (Pubitemid 43268401)
5. Tamura K, Hua B, Adachi S, et al. Stress response gene ATF3 is a target of c-myc in serum-induced cell proliferation. EMBO J 2005;24: 2590-601. (Pubitemid 41076315)
6. Thompson MR, Xu D, Williams BR. ATF3 transcription factor and its emerging roles in immunity and cancer. J Mol Med 2009;87:1053-60.
7. Pelzer AE, Bektic J, Haag P, et al. The expression of transcription factor activating transcription factor 3 in the human prostate and its regulation by androgen in prostate cancer. J Urol 2006;175:1517-22.
8. Janz M, Hummel M, Truss M, et al. Classical Hodgkin lymphoma is characterized by high constitutive expression of activating transcription factor 3 (ATF3), which promotes viability of Hodgkin/Reed-Sternberg cells. Blood 2006;107:2536-9. (Pubitemid 43345579)
9. Wang A, Arantes S, Yan L, et al. The transcription factor ATF3 acts as an oncogene in mouse mammary tumorigenesis. BMC Cancer 2008;8: 268.
10. Wu X, Nguyen BC, Dziunycz P, et al. Opposing roles for calcineurin and ATF3 in squamous skin cancer. Nature 2010;465:368-72.
11. Kolev V, Mandinova A, Guinea-Viniegra J, et al. EGFR signalling as a negative regulator of Notch1 gene transcription and function in proliferating keratinocytes and cancer. Nat Cell Biol 2008;10:902-11.
12. Saez E, Rutberg SE, Mueller E, et al. c-fos is required for malignant progression of skin tumors. Cell 1995;82:721-32.
13. Young MR, Li JJ, Rincon M, et al. Transgenic mice demonstrate AP-1 (activator protein-1) transactivation is required for tumor promotion. Proc Natl Acad Sci U S A 1999;96:9827-32. (Pubitemid 29398817)
14. Bandyopadhyay S, Wang Y, Zhan R, et al. The tumor metastasis suppressor gene Drg-1 down-regulates the expression of activating transcription factor 3 in prostate cancer. Cancer Res 2006;66: 11983-90. (Pubitemid 46094212)
15. Ishiguro T, Nagawa H, Naito M, et al. Inhibitory effect of ATF3 antisense oligonucleotide on ectopic growth of HT29 human colon cancer cells. Jpn J Cancer Res 2000;91:833-6.
16. Bottone FG, Martinez JM, Collins JB, et al. Gene modulation by the cyclooxygenase inhibitor, sulindac sulfide, in human colorectal carcinoma cells: possible link to apoptosis. J Biol Chem 2003;278: 25790-801. (Pubitemid 36835337)
17. Yan C, Lu D, Hai T, et al. Activating transcription factor 3, a stress sensor, activates p53 by blocking its ubiquitination. EMBO J 2005;24: 2425-35. (Pubitemid 41032593)
18. Yan C, Boyd DD. ATF3 regulates the stability of p53: a link to cancer. Cell Cycle 2006;5:926-9.
19. Berg D, Otley CC. Skin cancer in organ transplant recipients: epidemiology, pathogenesis, and management. J Am Acad Dermatol 2002;47:1-17 quiz 8-20.
20. Ulrich C, Kanitakis J, Stockfleth E, et al. Skin cancer in organ transplant recipients - where do we stand today? Am J Transplant 2008;8:2192-8.
21. Berg D, Otley CC. Skin cancer in organ transplant recipients: epidemiology, pathogenesis, and management. J Am Acad Dermatol 2002;47:1-17.
22. Cassarino DS, DeRienzo DP, Barr RJ. Cutaneous squamous cell carcinoma: a comprehensive clinicopathologic classification. J Cutan Pathol 2006;33:261-79.
23. Perrem K, Lynch A, Conneely M, et al. The higher incidence of squamous cell carcinoma in renal transplant recipients is associated with increased telomere lengths. Hum Pathol 2007;38:351-8. (Pubitemid 46096562)
24. Drake AL, Walling HW. Variations in presentation of squamous cell carcinoma in situ (Bowen's disease) in immunocompromised patients. J Am Acad Dermatol 2008;59:68-71.
25. Herman S, Rogers HD, Ratner D. Immunosuppression and squamous cell carcinoma: a focus on solid organ transplant recipients. Skinmed 2007;6:234-8.